BioLineRx Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 6.513 million compared to USD 5.566 million a year ago. Net loss was USD 6.842 million compared to USD 6.770 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago. For the half year, operating loss was USD 11.962 million compared to USD 12.406 million a year ago. Net loss was USD 17.034 million compared to USD 13.415 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.07 a year ago.